Sap Kidney Center Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-07-2024
- Paid Up Capital ₹ 0.10 M
as on 02-07-2024
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.88 M
as on 02-07-2024
- Revenue %
(FY 2023)
- Profit -24.15%
(FY 2023)
- Ebitda 5.18%
(FY 2023)
- Net Worth -2.40%
(FY 2023)
- Total Assets -14.96%
(FY 2023)
About Sap Kidney Center
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.88 M.
Mohammed Khan, Mohammed Khan, Pasha Begum, and One other member serve as directors at the Company.
- CIN/LLPIN
U86909TG2018PTC121647
- Company No.
121647
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sap Kidney Center?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohammed Khan  | Director | 05-Jan-2018 | Current |
| Mohammed Khan | Director | 05-Jan-2018 | Current |
| Pasha Begum | Director | 05-Jan-2018 | Current |
| Mohammed Khan | Director | 05-Jan-2018 | Current |
Financial Performance and Corporate Structure Insights of Sap Kidney Center.
Sap Kidney Center Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 24.15% decrease in profit. The company's net worth dipped by a decrease of 2.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sap Kidney Center?
In 2023, Sap Kidney Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sap Medicals Private LimitedActive 16 years 2 monthsMohammed Khan, Mohammed Khan and 2 more are mutual person
One Medical Devices Private LimitedActive 3 years 9 monthsMohammed Khan and Pasha Begum are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Jul 2023 | ₹6.88 M | Open |
How Many Employees Work at Sap Kidney Center?
Unlock and access historical data on people associated with Sap Kidney Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sap Kidney Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sap Kidney Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
